Bridgeway Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,100
Closed -$4.5M 1365
2021
Q4
$4.5M Hold
29,100
0.08% 365
2021
Q3
$4.94M Hold
29,100
0.09% 325
2021
Q2
$4.59M Sell
29,100
-100
-0.3% -$14.9K 0.08% 340
2021
Q1
$4.05M Hold
29,200
0.08% 340
2020
Q4
$5.11M Hold
29,200
0.11% 243
2020
Q3
$5.71M Buy
29,200
+9,500
+48% +$1.59M 0.13% 181
2020
Q2
$3.35M Buy
19,700
+1,000
+5% +$149K 0.07% 272
2020
Q1
$2.16M Buy
+18,700
New +$2.07M 0.05% 317

Other funds holding SGEN

Bridgeway Capital Management's SGEN Position: Q1 2022 in Review

Bridgeway Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q1 2022, closing a stake of 29,100 shares — an estimated $4.5M sold.

Bridgeway Capital Management first reported a position in SGEN in Q1 2020 and held it in 8 quarters. The position peaked at $5.71M in Q3 2020. 505 funds tracked by Wall St. Rank hold SGEN as of Q1 2022.

  • Bridgeway Capital Management reported no remaining Seagen Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 29,100 Seagen Inc. Common Stock shares in Q1 2022, an estimated $4.5M.
  • Bridgeway Capital Management first reported a position in Seagen Inc. Common Stock in Q1 2020 and held it in 8 quarters.
  • Bridgeway Capital Management's Seagen Inc. Common Stock position peaked at $5.71M in Q3 2020.
  • 505 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2022.

Based on Bridgeway Capital Management's 13F filing for Q1 2022, filed 16 May 2022.